Abstract
The lymphoproliferative disorders compromise a large group of entities that were classified by the World Health Organization according to clinical characteristics, histology, immunophenotyping and cytogenetic/molecular abnormalities. Treatment and long-term outcome are different for each type and are mainly driven by the subtype of lymphoma. In this overview, the characteristics of the five most common subtypes are described. Clinical characteristics, staging procedures, treatment and new trends are discussed.
| Translated title of the contribution | New developments in lymphoproliferative disorders |
|---|---|
| Original language | Dutch |
| Pages (from-to) | 563-569 |
| Number of pages | 7 |
| Journal | Tijdschrift voor Geneeskunde |
| Volume | 73 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 1 May 2017 |